Titan Pharmaceuticals, Inc. financial reports, Titan Pharmaceuticals, Inc. annual revenue in 2024. When does Titan Pharmaceuticals, Inc. report revenue?
Titan Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of Titan Pharmaceuticals, Inc. on 31/03/2021 amounted to 682 000 $. The dynamics of Titan Pharmaceuticals, Inc. net revenue grew by 682 000 $ compared to the previous report. The dynamics of Titan Pharmaceuticals, Inc. net income fell by -9 000 $. The assessment of the dynamics of Titan Pharmaceuticals, Inc. net income was made in comparison with the previous report. The financial report chart shows the values from 30/06/2017 to 31/03/2021. Titan Pharmaceuticals, Inc. net income is shown in blue on the graph. A graph of the value of all Titan Pharmaceuticals, Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
682 000 $
-27.831 % ↓
-2 641 000 $
-
31/12/2020
0 $
-100 % ↓
0 $
-
30/09/2020
1 120 000 $
+18.27 % ↑
-4 932 000 $
-
30/06/2020
1 325 000 $
+163.94 % ↑
-4 641 000 $
-
30/09/2019
947 000 $
-
-2 803 000 $
-
30/06/2019
502 000 $
-
-5 197 000 $
-
31/03/2019
945 000 $
-
-4 517 000 $
-
31/12/2018
1 237 000 $
-
-3 504 000 $
-
30/09/2018
1 650 000 $
-
-2 045 000 $
-
30/06/2018
2 668 000 $
-
-869 000 $
-
31/03/2018
1 064 000 $
-
-2 605 000 $
-
31/12/2017
58 000 $
-
-3 660 000 $
-
30/09/2017
40 000 $
-
-4 191 000 $
-
30/06/2017
77 000 $
-
-3 451 000 $
-
Show:
to
Titan Pharmaceuticals, Inc. financial report charts
The dates of the latest financial statements of Titan Pharmaceuticals, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Titan Pharmaceuticals, Inc. is 31/03/2021. Gross profit Titan Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Titan Pharmaceuticals, Inc. is -1 305 000 $
Titan Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Titan Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Titan Pharmaceuticals, Inc. is 1 987 000 $ Total revenue Titan Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Titan Pharmaceuticals, Inc. is 682 000 $ Operating income Titan Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Titan Pharmaceuticals, Inc. is -2 632 000 $
Net income Titan Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Titan Pharmaceuticals, Inc. is -2 641 000 $ Current assets Titan Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Titan Pharmaceuticals, Inc. is 13 189 000 $ Total assets Titan Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Titan Pharmaceuticals, Inc. is 13 824 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-1 305 000 $
-
-1 125 000 $
-910 000 $
-860 000 $
-1 651 000 $
-1 203 000 $
-908 000 $
-438 000 $
741 000 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 987 000 $
-
2 245 000 $
2 235 000 $
1 807 000 $
2 153 000 $
2 148 000 $
2 145 000 $
2 088 000 $
1 927 000 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
682 000 $
-
1 120 000 $
1 325 000 $
947 000 $
502 000 $
945 000 $
1 237 000 $
1 650 000 $
2 668 000 $
1 064 000 $
58 000 $
40 000 $
77 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
947 000 $
502 000 $
945 000 $
1 237 000 $
1 650 000 $
2 668 000 $
1 064 000 $
58 000 $
40 000 $
77 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-2 632 000 $
-2 632 000 $
-4 674 000 $
-4 384 000 $
-3 883 000 $
-4 882 000 $
-4 285 000 $
-3 266 000 $
-1 952 000 $
-639 000 $
-2 407 000 $
-3 374 000 $
-4 070 000 $
-3 621 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-2 641 000 $
-
-4 932 000 $
-4 641 000 $
-2 803 000 $
-5 197 000 $
-4 517 000 $
-3 504 000 $
-2 045 000 $
-869 000 $
-2 605 000 $
-3 660 000 $
-4 191 000 $
-3 451 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
1 907 000 $
1 907 000 $
1 907 000 $
1 844 000 $
1 844 000 $
1 856 000 $
2 307 000 $
2 714 000 $
2 501 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
3 314 000 $
-
5 794 000 $
5 709 000 $
4 830 000 $
5 384 000 $
5 230 000 $
4 503 000 $
3 602 000 $
3 307 000 $
3 471 000 $
3 432 000 $
4 110 000 $
3 698 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
13 189 000 $
7 328 000 $
6 649 000 $
8 690 000 $
3 946 000 $
5 493 000 $
10 089 000 $
13 301 000 $
11 525 000 $
4 193 000 $
4 749 000 $
8 310 000 $
12 056 000 $
8 754 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
13 824 000 $
8 087 000 $
8 018 000 $
9 762 000 $
5 304 000 $
6 761 000 $
11 440 000 $
14 095 000 $
11 854 000 $
4 617 000 $
5 290 000 $
8 905 000 $
12 740 000 $
9 414 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
11 629 000 $
5 413 000 $
4 073 000 $
5 498 000 $
921 000 $
2 292 000 $
5 909 000 $
9 295 000 $
8 427 000 $
1 614 000 $
3 826 000 $
7 522 000 $
11 688 000 $
8 350 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
3 482 000 $
4 342 000 $
4 761 000 $
3 452 000 $
2 202 000 $
2 389 000 $
-
3 000 000 $
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
3 465 000 $
7 522 000 $
11 688 000 $
8 350 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
7 964 000 $
7 332 000 $
8 385 000 $
7 264 000 $
6 365 000 $
5 930 000 $
-
6 584 000 $
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
150.15 %
108.45 %
73.30 %
51.54 %
53.69 %
128.44 %
-
73.94 %
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
9 980 000 $
3 532 000 $
-897 000 $
1 560 000 $
-2 660 000 $
-571 000 $
3 055 000 $
6 831 000 $
5 489 000 $
-1 313 000 $
-846 000 $
857 000 $
4 038 000 $
7 538 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-3 325 000 $
-4 149 000 $
-4 308 000 $
-3 308 000 $
-2 268 000 $
-1 856 000 $
-999 000 $
-3 863 000 $
-3 545 000 $
-2 520 000 $
Last revenue report of Titan Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Titan Pharmaceuticals, Inc. was 682 000 US dollar and changed by -27.831% since last year. Net income in Titan Pharmaceuticals, Inc. was -2 641 000 $ in last quartal, net income changes to 0%.
Current cash Titan Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Titan Pharmaceuticals, Inc. is 11 629 000 $
Titan Pharmaceuticals, Inc. stocks data
TTNP stock price
Titan Pharmaceuticals, Inc. stock price today, TTNP stock quote.
